Michelle Gilson
Director · Rani Therapeutics Holdings, Inc.
- 2024
- Aug 5, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michelle Gilson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- South Cone Investments Limited Partnership - $15.71M in RANI purchases and sales in the last 12 months
- Mir A. Imran - $1.29M in RANI purchases and sales in the last 12 months
- Talat Imran - $25K in RANI purchases and sales in the last 12 months
- Alireza Javadi - $301 in RANI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michelle Gilson?
Michelle Gilson is a corporate insider, tracked as Director of Rani Therapeutics Holdings, Inc. (RANI). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michelle Gilson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michelle Gilson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($5.03M) across all tracked filings.
